{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:09:03Z","timestamp":1790197743299,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ab.2026.116222","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:59:53Z","timestamp":1786633193000},"page":"116222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of a liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) method to quantify protoporphyrin IX (PPIX) and zinc (II) protoporphyrin IX (Zn-PPIX), in human plasma"],"prefix":"10.1016","volume":"719","author":[{"given":"Bhavik","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-3706","authenticated-orcid":false,"given":"Pete","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ab.2026.116222_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/hep.1840080235","article-title":"The liver in protoporphyria","volume":"8","author":"Bloomer","year":"1988","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ab.2026.116222_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000657","article-title":"Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria","volume":"9","author":"Levy","year":"2025","journal-title":"Hepatol. Commun."},{"issue":"9","key":"10.1016\/j.ab.2026.116222_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/lt.22341","article-title":"Liver transplantation for erythropoietic protoporphyria in Europe","volume":"17","author":"Wahlin","year":"2011","journal-title":"Liver Transplant."},{"issue":"8","key":"10.1016\/j.ab.2026.116222_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"34","key":"10.1016\/j.ab.2026.116222_bib5","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.1074\/jbc.M111.306423","article-title":"X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the \u03b2-Subunit of Succinyl-CoA synthetase (SUCLA2)","volume":"287","author":"Bishop","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ab.2026.116222_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16027","article-title":"Erythropoietic protoporphyrias: pathogenesis, diagnosis and management","volume":"45","author":"Minder","year":"2025","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.ab.2026.116222_bib7","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/bjd.15228","article-title":"Patients with erythropoietic protoporphyria have reduced erythrocyte protoporphyrin IX from early in pregnancy","volume":"177","author":"Heerfordt","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ab.2026.116222_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2133.1998.02333.x","article-title":"Erythropoietic protoporphyria improving during pregnancy","volume":"139","author":"Bewley","year":"1998","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ab.2026.116222_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0190-9622(97)70323-2","article-title":"Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy","volume":"36","author":"Poh-Fitzpatrick","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.ab.2026.116222_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6127","article-title":"The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria","volume":"5","author":"Wang","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ab.2026.116222_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54969-6","article-title":"Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ab.2026.116222_bib12","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2004-04-1566","article-title":"Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels","volume":"105","author":"Zhou","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ab.2026.116222_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2015.245456","article-title":"Pitfalls in erythrocyte protoporphyrin measurement for diagnosis and monitoring of protoporphyrias","volume":"61","author":"Gou","year":"2015","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ab.2026.116222_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.301.2.507","article-title":"Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer","volume":"301","author":"Dalton","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"17","key":"10.1016\/j.ab.2026.116222_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9138","article-title":"Protoporphyrin IX purification from blood and serum for mass analysis - considerations with respect to neurosurgery","volume":"35","author":"Walke","year":"2021","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"6","key":"10.1016\/j.ab.2026.116222_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ab.2026.116222_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05780-w","article-title":"Protoporphyrin IX plasma and blood pharmacokinetics and brain tumor distribution determined by a validated LC\u2013MS\/MS method","volume":"15","author":"Knight","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:50:09Z","timestamp":1790196609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269726001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":17,"alternative-id":["S0003269726001788"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2026.116222","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) method to quantify protoporphyrin IX (PPIX) and zinc (II) protoporphyrin IX (Zn-PPIX), in human plasma","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2026.116222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116222"}}